Sadar MD - Search Results

1

An androgen receptor N-terminal domain antagonist for treating prostate cancer.

Myung JK, Banuelos CA, Fernandez JG, Mawji NR, Wang J, Tien AH, Yang YC, Tavakoli I, Haile S, Watt K, McEwan IJ, Plymate S, Andersen RJ, Sadar MD. Myung JK, et al. Among authors: sadar md. J Clin Invest. 2013 Jul;123(7):2948-60. doi: 10.1172/JCI66398. Epub 2013 Jun 3. J Clin Invest. 2013. PMID: 23722902 Free PMC article.

2

Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaP.

Sato N, Sadar MD, Bruchovsky N, Saatcioglu F, Rennie PS, Sato S, Lange PH, Gleave ME. Sato N, et al. Among authors: sadar md. J Biol Chem. 1997 Jul 11;272(28):17485-94. doi: 10.1074/jbc.272.28.17485. J Biol Chem. 1997. PMID: 9211894 Free article.

3

Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways.

Sadar MD. Sadar MD. J Biol Chem. 1999 Mar 19;274(12):7777-83. doi: 10.1074/jbc.274.12.7777. J Biol Chem. 1999. PMID: 10075669 Free article.

4

Prostate cancer: molecular biology of early progression to androgen independence.

Sadar MD, Hussain M, Bruchovsky N. Sadar MD, et al. Endocr Relat Cancer. 1999 Dec;6(4):487-502. doi: 10.1677/erc.0.0060487. Endocr Relat Cancer. 1999. PMID: 10730903 Review.

5

Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells.

Sadar MD, Gleave ME. Sadar MD, et al. Cancer Res. 2000 Oct 15;60(20):5825-31. Cancer Res. 2000. PMID: 11059779

6

Intermittent androgen suppression for prostate cancer: Canadian Prospective Trial and related observations.

Bruchovsky N, Klotz LH, Sadar M, Crook JM, Hoffart D, Godwin L, Warkentin M, Gleave ME, Goldenberg SL. Bruchovsky N, et al. Mol Urol. 2000 Fall;4(3):191-9;discussion 201. Mol Urol. 2000. PMID: 11062374 Clinical Trial.

7

Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways.

Ueda T, Bruchovsky N, Sadar MD. Ueda T, et al. Among authors: sadar md. J Biol Chem. 2002 Mar 1;277(9):7076-85. doi: 10.1074/jbc.M108255200. Epub 2001 Dec 19. J Biol Chem. 2002. PMID: 11751884 Free article.

8

Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells.

Ueda T, Mawji NR, Bruchovsky N, Sadar MD. Ueda T, et al. Among authors: sadar md. J Biol Chem. 2002 Oct 11;277(41):38087-94. doi: 10.1074/jbc.M203313200. Epub 2002 Aug 5. J Biol Chem. 2002. PMID: 12163482 Free article.

9

Androgens and androgen receptor in prostate and ovarian malignancies.

Meehan KL, Sadar MD. Meehan KL, et al. Among authors: sadar md. Front Biosci. 2003 May 1;8:d780-800. doi: 10.2741/1063. Front Biosci. 2003. PMID: 12700055 Review.

10

Osteoblast-derived factors induce androgen-independent proliferation and expression of prostate-specific antigen in human prostate cancer cells.

Blaszczyk N, Masri BA, Mawji NR, Ueda T, McAlinden G, Duncan CP, Bruchovsky N, Schweikert HU, Schnabel D, Jones EC, Sadar MD. Blaszczyk N, et al. Among authors: sadar md. Clin Cancer Res. 2004 Mar 1;10(5):1860-9. doi: 10.1158/1078-0432.ccr-0974-3. Clin Cancer Res. 2004. PMID: 15014041

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters